NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,497 | -16.6% | 16,367 | -14.4% | 0.00% | -33.3% |
| Q2 2023 | $142,039 | -13.4% | 19,117 | -19.2% | 0.00% | 0.0% |
| Q1 2023 | $164,012 | -34.3% | 23,667 | -2.5% | 0.00% | -50.0% |
| Q4 2022 | $249,465 | -59.7% | 24,267 | -28.6% | 0.01% | -57.1% |
| Q3 2022 | $619,000 | -78.0% | 33,988 | -37.8% | 0.01% | -77.0% |
| Q2 2022 | $2,811,000 | -36.0% | 54,652 | -8.3% | 0.06% | -22.8% |
| Q1 2022 | $4,390,000 | -30.5% | 59,602 | +35.0% | 0.08% | -28.2% |
| Q4 2021 | $6,317,000 | +1.7% | 44,150 | +47.4% | 0.11% | -5.2% |
| Q3 2021 | $6,210,000 | +477.7% | 29,953 | +491.8% | 0.12% | +510.5% |
| Q2 2021 | $1,075,000 | +3.5% | 5,061 | -11.6% | 0.02% | -9.5% |
| Q1 2021 | $1,039,000 | +133.0% | 5,727 | +43.3% | 0.02% | +133.3% |
| Q4 2020 | $446,000 | +6.7% | 3,997 | +3.5% | 0.01% | -10.0% |
| Q3 2020 | $418,000 | -36.7% | 3,860 | -51.2% | 0.01% | -41.2% |
| Q2 2020 | $660,000 | +72.8% | 7,917 | -71.9% | 0.02% | +41.7% |
| Q1 2020 | $382,000 | – | 28,183 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 90,000 | $4,629,000 | 1.95% |
| Affinity Asset Advisors, LLC | 85,000 | $4,372,000 | 1.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,814 | $132,500,000 | 1.38% |
| Mendel Capital Management LLC | 23,835 | $1,226,000 | 1.37% |
| Faithward Advisors, LLC | 80,143 | $4,122,000 | 0.92% |
| Coatue Management | 1,241,716 | $63,861,000 | 0.77% |
| Rock Springs Capital Management LP | 475,100 | $24,434,000 | 0.71% |
| SECTOR GAMMA AS | 55,324 | $2,845,000 | 0.64% |
| SevenOneSeven Capital Management | 5,103 | $262,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 49,200 | $2,530,000 | 0.51% |